Use of Idarucizumab to Revert the Anticoagulant Effect of Dabigatran in Heart Transplant Surgery: An Institutional Experience

Use of Idarucizumab to Revert the Anticoagulant Effect of Dabigatran in Heart Transplant Surgery: An Institutional Experience

Heart transplant is a surgical procedure with a high risk of perioperative bleeding in patients with a previous history of sternotomy, congestive liver disease, and/or use of oral anticoagulants. Anticoagulation is usually done with coumarin agents (warfarin, acenocoumarol), while on the waiting lis...

Full description

Bibliographic Details
Main Authors:	Álvaro Herrera-Escandón, Orlando Castaño-Cifuentes, Carlos A. Plata-Mosquera
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Case Reports in Cardiology
Online Access:	http://dx.doi.org/10.1155/2020/6927423

Similar Items

Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran
by: Sié P
Published: (2016-05-01)

Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal
by: Proietti M, et al.
Published: (2018-08-01)

Dabigatran reversal with idarucizumab in a patient undergoing heart transplantation: first European report
by: António Tralhão, et al.
Published: (2017-09-01)

The new way of Dabigatran reversal – Idarucizumab
by: Erwin Ciechański, et al.
Published: (2019-02-01)

Reversal of Dabigatran with Idarucizumab in Acute Subarachnoid Hemorrhage
by: Jonathan Balakumar, et al.
Published: (2017-10-01)

Reversal of anticoagulation effect of dabigatran with idarucizumab, for thrombolysis in acute ischemic stroke: Inimicus inimico amicus
by: Boby V Maramattom, et al.
Published: (2019-01-01)

Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report
by: Sergio Agosti, et al.
Published: (2017-08-01)

Idarucizumab as Antidote to Intracerebral Hemorrhage under Treatment with Dabigatran
by: Valentin Held, et al.
Published: (2016-10-01)

Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study
by: Masahiro Yasaka, et al.
Published: (2020-03-01)

Idarucizumab for a traumatic head injury patient taking dabigatran
by: Shuhei Maruyama, et al.
Published: (2018-10-01)

Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals
by: Jameel Abdulrehman, et al.
Published: (2021-07-01)

Intravenous Thrombolysis after Reversal of Dabigatran by Idarucizumab: A Case Report
by: Waldemar Kafke, et al.
Published: (2016-06-01)

Use of Idarucizumab for dabigatran reversal: Emergency department experience in two cases with subdural haematoma
by: Gail Edwards, et al.
Published: (2018-02-01)

Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab
by: Gian Galeazzo Riario Sforza, et al.
Published: (2018-01-01)

Immediate Reversal of Dabigatran by Idarucizumab Prior to Laboratory and Imaging Results in Acute Stroke
by: Maren Hieber, et al.
Published: (2019-03-01)

Idarucizumab for Dabigatran Reversal-full Cohort Analysis (RE-VERSE AD Study)
by: Esme Ekizoğlu
Published: (2018-06-01)

Intravenous Thrombolysis After Dabigatran Reversal by Idarucizumab: A Systematic Review of the Literature
by: Senta Frol, et al.
Published: (2021-06-01)

Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution.
by: Oliver Grottke, et al.
Published: (2019-01-01)

First Reported Case of Hemopericardium Related to Dabigatran Use Reversed by New Antidote Idarucizumab
by: Steven Song, et al.
Published: (2017-01-01)

Difficult reversal of dabigatran with idarucizumab in a multiple-trauma patient: A question of dose?
by: Mathias Ströhle, et al.
Published: (2021-04-01)

[Budget impact analysis of idarucizumab for the management of patients treated with dabigatran in emergency / urgent situations in Italy]
by: Andrea Belisari, et al.
Published: (2016-06-01)

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab
by: Hu TY, et al.
Published: (2016-02-01)

Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World Setting
by: Nicolas Gendron, et al.
Published: (2020-12-01)

Reversal of Dabigatran Using Idarucizumab in a Septic Patient with Impaired Kidney Function in Real-Life Practice
by: Thomas C. Sauter, et al.
Published: (2016-01-01)

The preoperative management of dabigatran and its specific antidote idarucizumab in patients with nonvalvular atrial fibrillation: Case reports
by: Tomić Milan
Published: (2020-01-01)

Idarucizumab in High-risk Thoracic Surgery
by: R L�pez Vilella, et al.
Published: (2018-04-01)

Anticoagulant-related bleeding in patients with heart failure in combination with chronic obstructive pulmonary disease and atrial fibrillation. Experience with Idarucizumab
by: L. A. Shpagina, et al.
Published: (2020-06-01)

Successful intravenous thrombolysis in acute ischemic stroke after reversal of dabigatran etexilate with idarucizumab at the end of therapeutic time window
by: Gorana Vukorepa, et al.
Published: (2020-01-01)

Anticoagulant Related Nephropathy Induced by Dabigatran
by: Nazia Sharfuddin, et al.
Published: (2018-01-01)

New options with dabigatran etexilate in anticoagulant therapy
by: Lars Maegdefessel, et al.
Published: (2010-05-01)

Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report
by: Toshiyuki Ohtani, et al.
Published: (2019-12-01)

Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran
by: Giannandrea D, et al.
Published: (2019-05-01)

Safety of Dabigatran as an Anticoagulant: A Systematic Review and Meta-Analysis
by: Ya Zhou, et al.
Published: (2021-02-01)

Contribution of novel anticoagulants fondaparinux and dabigatran to venous thromboembolism prevention
by: Antonijević Nebojša, et al.
Published: (2015-01-01)

Dabigatran etexilate - A novel oral anticoagulant for bleeding complications
by: Himabindu Reddy, et al.
Published: (2015-09-01)

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
by: Choi JC, et al.
Published: (2014-02-01)

Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate
by: L Bellamy, et al.
Published: (2009-07-01)

No influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic stroke.
by: Ferdinand Bohmann, et al.
Published: (2012-01-01)

Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures
by: Marcus Vinicius Santos Andrade, et al.
Published: (2018-08-01)

Thrombolysis in a Stroke Patient on Dabigatran Anticoagulation: Case Report and Synopsis of Published Cases
by: Waltraud Pfeilschifter, et al.
Published: (2013-03-01)